Amid the rapidly evolving global coronavirus disease 2019 (COVID-19) pandemic that has already had profound effects on public health and medical infrastructure across the globe, many questions remain about its impact on child health. New research published in the Journal of Clinical Virology indicates that the vulnerability of neonates and children and their role in the spread of the virus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) should be included in preparedness and response plans.
According to lead author Kathleen M. Muldoon, Ph.D., Associate Professor, Anatomy at the Arizona College of Osteopathic Medicine at Midwestern University, the COVID-19 pandemic poses substantial and underappreciated risks to pregnant women, and perinatal infections endanger pregnancy outcomes. “Studies to date suggest that the virus can be transmitted to the fetus in utero,” Dr. Muldoon says. “Although the evidence for infection is under debate, the possible routes for infection are such that infection control measures are required to protect newborns.”
The potential for neonatal infection with the COVID-19 virus demands intensive study, including how viral pathology may or may not affect breast milk as the preferred method of infant nutrition, as well as the potential effects of vaccines on women of child-bearing age, unborn fetuses, and newborn infants.
“We are presenting the state of knowledge acquired to date about potential risks of transmission of SARS-CoV-2 to the fetus and newborn,” continues Dr. Muldoon. “This research is timely because information regarding the potential routes of acquisition of SARS-CoV-2 infection in the prenatal and perinatal setting is of a high public health priority. Vaccines targeting women of reproductive age, and in particular pregnant patients, should be evaluated in clinical trials and should include the endpoints of neonatal infection and disease.”
Follow the latest news on the coronavirus (COVID-19) outbreak
Kathleen M. Muldoon et al, SARS-CoV-2: Is it the Newest Spark in the TORCH?, Journal of Clinical Virology (2020). DOI: 10.1016/j.jcv.2020.104372
COVID-19 and pregnancies: What we know (2020, April 27)
retrieved 27 April 2020
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022